Vorsitz: J. Heineke (Hannover), T. Wieland (Mannheim)
| (V503) | Effects of TRPC4α and TRPC4β on cardiomyocyte hypertrophy and viability |
|
| S. Bandleon, N. Kirschmer, V. von Ehrlich-Treuenstätt, A. Schaaf, S. Hartmann, D. Höfler, C. Manske, O. Ritter, P. Eder-Negrin (Würzburg, Brandenburg) | ||
| Diskussion | ||
| (V504) | Early signs of mitochondrial complex dysfunction in both SSM and IFM in pressure overload induced cardiac hypertrophy may indicate subsequent development of heart failure | |
| M. Schwarzer, C. Werner, M. Osterholt, A. Schrepper, T. Doenst (Jena, Überlingen) | ||
| Diskussion | ||
| (V505) | Proteasome inhibition in experimental right ventricular hypertrophy: A novel therapeutic approach? | |
| T. Heitmeier, A. Sydykov, C. Lukas, C. Vroom, M. Korfei, A. Günther, O. Eickelberg, N. Weissmann, A. Ghofrani, W. Seeger, F. Grimminger, R. Schermuly, S. Meiners, D. Kosanovic , DZL (Gießen, München) | ||
| Diskussion | ||
| (V506) | NFAT decoy oligonucleotide prevention of myocardial hypertrophy | |
| A. Remes, A. Jungmann, N. Ullrich, H. A. Katus, O. J. Müller, M. Hecker, A. H. Wagner (Heidelberg) | ||
| Diskussion | ||
| (V507) | The H19 long non-coding RNA regulates pathological cardiac hypertrophy | |
| J. A. Kleeberger, J. Viereck, R. Kumarswamy, S. Batkai, A. Foinquinos, F. Weidemann, T. Thum (Hannover, Würzburg) | ||
| Diskussion | ||
| (V508) | Cardiomyocyte telomere dynamics upon neurohormonal activation in myocardial hypertrophy and heart failure and effects on cellular function | |
| M. Brandt, V. S. Garlapati, U. Raaz, J. Ramunas, C. Holbrook, P. S. Tsao, T. Münzel, H. Blau, P. Wenzel (Mainz, Göttingen, Palo Alto; Stanford, US) | ||
| Diskussion |
| 12:30 - 13:00 | M i t t a g s p a u s e |